Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1591-1600 of 9367

Page
per page
  1. BLU9931
    A8706 BLU9931
    Target: FGFR
    Summary: FGFR4 inhibitor,potent and irreversible
      ≥50.9 mg/mL
  2. Darunavir Ethanolate
    B4950 Darunavir Ethanolate
    Summary: nonpeptidic HIV protease inhibitor
      ≥59.17 mg/mL
  3. Chlorothiazide Sodium
    B4951 Chlorothiazide Sodium
    Summary: diuretic and antihypertensive
      ≥31.8 mg/mL
  4. Enalaprilat
    B4952 Enalaprilat
    Summary: angiotensin-converting enzyme (ACE) inhibitor
      Soluble in DMSO
  5. Methylprednisolone Sodium Succinate
    B4953 Methylprednisolone Sodium Succinate
    Target: Glucocorticoid Receptors
    Summary: glucocorticoid
      ≥49.7 mg/mL
  6. Tolbutamide Sodium
    B4957 Tolbutamide Sodium
    Summary: potassium channel blocker
      Soluble in DMSO
  7. Tobramycin Sulfate
    B4958 Tobramycin Sulfate
    Summary: broad-spectrum antibiotic
      insoluble in EtOH; insoluble in DMSO; ≥57.4 mg/mL
  8. Penciclovir Sodium
    B4960 Penciclovir Sodium
    Summary: antiviral drug
      ≥41.67 mg/mL
  9. Mesoridazine Besylate
    A8701 Mesoridazine Besylate
    Summary: Phenothiazine dopamine receptor anatagonist
      ≥54.58 mg/mL
  10. Thonzonium Bromide
    B4962 Thonzonium Bromide
    Summary: surface active agent and inhibitor of V-ATPase proton transport
      ≥53.5 mg/mL

Items 1591-1600 of 9367

Page
per page